Vivani Medical, Inc. (VANI)
USD 1.21
(-6.92%)
USD 1.21
(-6.92%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -23.69 Million | -18.78 Million | -10.95 Million | -7.61 Million | -27.62 Million | -29.81 Million |
| Net Income | -25.65 Million | -13.88 Million | -12.77 Million | -9.27 Million | -33.59 Million | -35.09 Million |
| Depreciation & Amortization | 357 Thousand | 381 Thousand | 345 Thousand | 354 Thousand | 414 Thousand | 435 Thousand |
| Deferred income taxes | 602 Thousand | - | - | - | -4.26 Million | - |
| Stock-based compensation | 1.86 Million | 1.29 Million | 1.66 Million | 1.03 Million | - | - |
| Change in working capital | -1.29 Million | 338 Thousand | 451 Thousand | 146 Thousand | 37 Thousand | 425 Thousand |
| Other non-cash items | 423 Thousand | -6.91 Million | -641 Thousand | 123 Thousand | 6.85 Million | 4.69 Million |
| Investing Cash Flow | -887 Thousand | -338 Thousand | -572 Thousand | -150 Thousand | -493 Thousand | -163 Thousand |
| Investments in PPE | -887 Thousand | -338 Thousand | -572 Thousand | -150 Thousand | -493 Thousand | -163 Thousand |
| Acquisitions | - | - | - | 398 Thousand | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | -398 Thousand | - | - |
| Financing Cash Flow | 133 Thousand | 63.39 Million | 11.62 Million | 9.18 Million | 34.98 Million | 26.6 Million |
| Debt repayment | - | -8 Million | - | -637 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -281 Thousand | - | - |
| Common Stock Issuance | 133 Thousand | 16 Thousand | 11.62 Million | 8.55 Million | 34.98 Million | 26.6 Million |
| Other Financing Activities | 133 Thousand | 71.37 Million | 11.62 Thousand | 918 Thousand | - | 665 Thousand |
| Accounts receivables | - | - | - | 461 Thousand | 48 Thousand | 1.22 Million |
| Accounts payables | -602 Thousand | -1.94 Million | 13 Thousand | -18 Thousand | -213 Thousand | 554 Thousand |
| Inventory | - | - | - | 529 Thousand | -347 Thousand | -1.17 Million |
| Other working capital | -691 Thousand | 2.27 Million | 438 Thousand | -826 Thousand | 549 Thousand | -171 Thousand |
| Cash at beginning of period | 45.07 Million | 2.17 Million | 2.08 Million | 663 Thousand | 4.47 Million | 7.83 Million |
| Cash at end of period | 20.65 Million | 46.44 Million | 2.17 Million | 2.08 Million | 11.32 Million | 4.47 Million |
| Capital Expenditure | -887 Thousand | -338 Thousand | -572 Thousand | -150 Thousand | -493 Thousand | -163 Thousand |
| Effect of forex changes on cash | 3000.00 | -1000.00 | - | - | -11 Thousand | 4000.00 |
| Net cash flow / Change in cash | -24.42 Million | 44.26 Million | 98 Thousand | 1.41 Million | 6.85 Million | -3.36 Million |
| Free Cash Flow | -24.58 Million | -19.12 Million | -11.52 Million | -7.76 Million | -28.12 Million | -29.97 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.35 Million | -6.03 Million | -25.65 Million | -6.02 Million | -6.78 Million | -6.52 Million |
| Depreciation & Amortization | 100 Thousand | 99 Thousand | 357 Thousand | 98 Thousand | 71 Thousand | 80 Thousand |
| Deferred income taxes | - | - | 602 Thousand | -656 Thousand | - | - |
| Stock-based compensation | 383 Thousand | 353 Thousand | 1.86 Million | 460 Thousand | 511 Thousand | 524 Thousand |
| Change in working capital | -35 Thousand | 993 Thousand | -1.29 Million | 1.79 Million | -2.2 Million | 182 Thousand |
| Other non-cash items | 690 Thousand | 633 Thousand | 423 Thousand | 852 Thousand | 701 Thousand | 190 Thousand |
| Investing Cash Flow | -37 Thousand | -182 Thousand | -887 Thousand | -743 Thousand | -63 Thousand | -44 Thousand |
| Investments in PPE | -37 Thousand | -182 Thousand | -887 Thousand | -743 Thousand | -63 Thousand | -44 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | 13.68 Million | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -13.68 Million | - | - | - | - |
| Financing Cash Flow | 109 Thousand | 13.69 Million | 133 Thousand | 23 Thousand | 103 Thousand | 7000.00 |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 109 Thousand | 13.69 Million | 133 Thousand | 23 Thousand | 103 Thousand | 7000.00 |
| Other Financing Activities | 109 Thousand | 13.69 Thousand | 133 Thousand | 23.00 | 103.00 | 7.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 80 Thousand | 27 Thousand | -602 Thousand | -1.32 Million | -104 Thousand | 1.25 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -35 Thousand | 993 Thousand | -691 Thousand | 3.11 Million | -2.09 Million | -1.06 Million |
| Cash at beginning of period | 29.64 Million | 20.65 Million | 45.07 Million | 24.82 Million | 33.85 Million | 39.43 Million |
| Cash at end of period | 24.91 Million | 29.64 Million | 20.65 Million | 20.65 Million | 26.18 Million | 33.85 Million |
| Capital Expenditure | -37 Thousand | -182 Thousand | -887 Thousand | -743 Thousand | -63 Thousand | -44 Thousand |
| Effect of forex changes on cash | - | -2000.00 | 3000.00 | 6000.00 | -3000.00 | -939 Thousand |
| Net cash flow / Change in cash | -4.72 Million | 8.99 Million | -24.42 Million | -4.16 Million | -7.66 Million | -5.58 Million |
| Free Cash Flow | -4.83 Million | -4.69 Million | -24.58 Million | -4.22 Million | -7.76 Million | -5.59 Million |
FDR
TRC
ITX
002968
300485
DELTA